Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin on Ventricular Arrhythmia in Heart Failure
NCT05550441Phase 4Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Nov 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dapagliflozin in heart failure (HF), ventricular arrhythmia (VA), sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT05550441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05550441.